Pharma-Bio Serv (PBSV) EBITDA Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -1,123.00 |
| Oct 31, 2025 | -922.00 |
| Jul 31, 2025 | -2,900.00 |
| Apr 30, 2025 | -1,682.00 |
| Jan 31, 2025 | -1,537.00 |
| Oct 31, 2024 | -1,545.00 |
| Jul 31, 2024 | -2,305.00 |
| Apr 30, 2024 | -2,244.00 |
| Jan 31, 2024 | -2,873.00 |
| Oct 31, 2023 | -1,021.00 |
| Jul 31, 2023 | -553.00 |
| Apr 30, 2023 | 856.00 |
| Jan 31, 2023 | 7,410.00 |
| Oct 31, 2022 | -562.00 |
| Jul 31, 2022 | 1,262.00 |
| Apr 30, 2022 | 1,393.00 |
| Jan 31, 2022 | 1,658.00 |
| Oct 31, 2021 | -7,603.00 |
| Jul 31, 2021 | 971.00 |
| Apr 30, 2021 | 307.00 |
| Jan 31, 2021 | 19.00 |
| Oct 31, 2020 | 352.00 |
| Jul 31, 2020 | 598.00 |
| Apr 30, 2018 | -1,665.00 |
| Jan 31, 2018 | -8,047.00 |
| Oct 31, 2017 | -755.00 |
| Jul 31, 2017 | -2,081.00 |
| Apr 30, 2017 | -2,853.00 |
| Jan 31, 2017 | -3,090.00 |
| Oct 31, 2016 | -2,621.00 |
| Jul 31, 2016 | -2,364.00 |
| Apr 30, 2016 | -1,389.00 |
| Jan 31, 2016 | -749.00 |
| Oct 31, 2015 | -949.00 |
| Jul 31, 2015 | 3.00 |